Margarita
López Trascasa
Publicaciones en las que colabora con Margarita López Trascasa (19)
2019
-
Complement as a diagnostic tool in immunopathology
Seminars in Cell and Developmental Biology, Vol. 85, pp. 86-97
2018
-
Common and rare genetic variants of complement components in human disease
Molecular Immunology, Vol. 102, pp. 42-57
-
Human plasma C3 is essential for the development of memory B, but not T, lymphocytes
Journal of Allergy and Clinical Immunology, Vol. 141, Núm. 3, pp. 1151-1154.e14
2017
-
Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy
Kidney International, Vol. 92, Núm. 4, pp. 953-963
-
Multimarker risk stratification approach at multiple sclerosis onset
Clinical Immunology, Vol. 181, pp. 43-50
2016
-
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy
Clinical and Experimental Immunology, Vol. 184, Núm. 1, pp. 118-125
2015
-
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome
Molecular Immunology, Vol. 66, Núm. 2, pp. 263-273
2013
-
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation
Journal of Clinical Investigation, Vol. 123, Núm. 6, pp. 2434-2446
2012
-
Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor H and factor H-related protein 1 to pentraxin 3
Journal of Immunology, Vol. 189, Núm. 4, pp. 1858-1867
-
Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance
Kidney International, Vol. 81, Núm. 1, pp. 56-63
2010
-
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation
Journal of Clinical Investigation, Vol. 120, Núm. 10, pp. 3702-3712
2008
-
Mutations in Proteins of the Alternative Pathway of Complement and the Pathogenesis of Atypical Hemolytic Uremic Syndrome
American Journal of Kidney Diseases, Vol. 52, Núm. 1, pp. 171-180
2007
-
Erratum: Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome (Proceeding of the National Academy of Science of the United States of America (January 2007) 104, (240-245))
Proceedings of the National Academy of Sciences of the United States of America
-
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 1, pp. 240-245
-
The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: Update and integration of membrane cofactor protein and factor I mutations with structural models
Human Mutation, Vol. 28, Núm. 3, pp. 222-234
2006
-
Insights into hemolytic uremic syndrome: Segregation of three independent predisposition factors in a large, multiple affected pedigree
Molecular Immunology, Vol. 43, Núm. 11, pp. 1769-1775
2005
-
Erratum: Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation of gene cluster in 1q32 (Human Molecular Genetics (2005) vol. 14 (703-712))
Human Molecular Genetics
-
Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32
Human Molecular Genetics, Vol. 14, Núm. 5, pp. 703-712
2004
-
The human complement factor H: Functional roles, genetic variations and disease associations
Molecular Immunology, Vol. 41, Núm. 4, pp. 355-367